Physician profile
Rex S Houser
NPI 1184622110
$14,272.02
in general payments reported to CMS, 2019-2025
64 companies · $2,501 in 2025
The $2,501 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,268 · 2020: $1,857 · 2021: $1,895 · 2022: $1,281 · 2023: $2,071 · 2024: $2,399 · 2025: $2,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,801 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,800.85 |
| Education | $170.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,386.70 | 2019-2025 | |
| Grifols USA, LLC | $845.26 | 2019-2025 | Gamunex-C |
| Acadia Pharmaceuticals INC | $835.91 | 2019-2025 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $825.00 | 2019-2025 | |
| Ucb, INC. | $780.71 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Amgen INC. | $678.52 | 2019-2025 | Uplizna, Aimovig |
| Biogen, INC. | $610.79 | 2019-2025 | Tysabri, Vumerity, Skyclarys |
| Sk Life Science, INC. | $518.01 | 2020-2025 | |
| Lilly USA, LLC | $458.63 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Genzyme Corporation | $452.84 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $415.45 | 2019-2021 | |
| Lundbeck LLC | $405.91 | 2019-2025 | Vyepti, Rexulti |
| Csl Behring | $388.61 | 2019-2025 | Hizentra |
| Mdd US Operations, LLC | $379.02 | 2019-2025 | Apokyn, Xadago, Gocovri |
| Pfizer INC. | $373.57 | 2019-2025 |
Show all 64 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Houser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.